SEC Info - National Health Investors Inc

i false i 0000877860 0000877860 2020-04-01 2020-04-01

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM i 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report : i April 1, 2020

i NATIONAL HEALTH INVESTORS INC

(Exact name of registrant as specified in its charter)



i Maryland	i 001-10822	i 62-1470956
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

i 222 Robert Rose Drive, i Murfreesboro, i TN i 37129

(Address of principal executive offices)

( i 615) i 890-9100

(Registrant's telephone number, including area code)

Not Applicable

(Former name, former address and former fiscal year,

if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):



i ☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
i ☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
i ☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
i ☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)

Securities registered pursuant to Section 12(b) of the Act:



Title of each Class	Trading Symbol(s)	Name of each exchange on which registered
i Common Stock, $0.01 par value	i NHI	i New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company i ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ‬ ☐

Item 7.01 Regulation FD

National Health Investors (NYSE: NHI) has prepared an update pertaining to the COVID-19 pandemic, which can be found at www.nhireit.com/covid-19/. NHI intends to update the information on a weekly basis after market hours subject to the timely receipt of new data from our operators and third-party data providers. The updates will only be made to the Company's website.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

NATIONAL HEALTH INVESTORS, INC.


By:	/s/*John L. Spaid*


Name:	John L. Spaid

Date: April 1, 2020

This ‘8-K’ Filing	Date	Other Filings

Filed on / For Period end:	4/1/20	None on these Dates
		List all Filings

National Health Investors Inc – ‘8-K’ for 4/1/20

On: Wednesday, 4/1/20, at 4:35pm ET · For: 4/1/20 · Accession #: 877860-20-49 · File #: 1-10822

Previous ‘8-K’: ‘8-K’ on / for 3/23/20 · Next: ‘8-K’ on / for 4/3/20 · Latest: ‘8-K’ on / for 2/26/24

Current Report — Form 8-K — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

‘8-K’ — Current Report

This is an HTML Document rendered as filed. [ Alternative Formats ]

Dates Referenced Herein